MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

MiniMed Group, Inc. Common StockNASDAQ: MMED

Revenue · Q1 FY2026 · quarter ended Jul 2026

Revenue of $843M in Q1 FY2026

Q1 FY2026 revenue was $843M. Trailing-twelve-month revenue was $3.22B. Over 3 fiscal years it compounded at +11.4% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 11 analysts of $3.44B (+10.9%) for the fiscal year ending Apr 2027, a slowdown from the +14.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
$843M+0.7% QoQ
Last fiscal yearApr 2026
$3.1B+14.3% YoY
LTMJul 2026
$3.22B— YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter—+9.7%—
1 year+14.3%+10.9%-3.4 pp
3-year CAGR+11.4%+9.6%-1.7 pp
5-year CAGR+10.2%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
3.1B USD
Year-over-year change
+14.3%
3-year CAGR
+11.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 revenue of $3.22B is the 3rd highest of the 7 companies compared; the peer median is $2.04B.
  • Over three fiscal years its annual growth of +11.4% compares with a peer median of +22.3%.
MMED Competitors Peer median
Revenue for MMED and competitors
Company Period LTM YoY 3-year CAGR
MDTMedtronic plcLTM Jul 2026$37.54B +9.8%+5.2%
DXCMDexCom, Inc.LTM Jun 2026$4.97B +15.5%+17.0%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$3.22B —+11.4%
PODDInsulet CorporationLTM Jun 2026$3.05B +29.4%+27.5%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$1.03B -6.8%+8.2%
BBNXBeta Bionics, Inc.LTM Mar 2026$110.24M +57.9%+724.3%
SENSSenseonics Holdings, Inc.LTM Mar 2026$40.71M +71.9%+29.1%
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding MMED) $2.04B+22.5%+22.3%

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Revenue2.25B2.47B2.72B3.1B
Cost of Revenue937M1.03B1.19B1.42B
Gross Profit1.31B1.44B1.53B1.68B
Gross Margin58.3%58.2%56.2%54.2%
Research & Development429M437M438M448M
Selling, General & Admin960M1.06B1.13B1.18B
Operating Expenses1.38B1.51B1.73B1.63B
Depreciation & Amortization115M129M143M156M
EBITDA39M59M107M205M
EBITDA Margin1.7%2.4%3.9%6.6%
Operating Income(69M)(69M)(202M)49M
Operating Margin-3.1%-2.8%-7.4%1.6%
Interest Income0000
Interest Expense0000
Other Income / Expenses(7M)(1M)(1M)(236M)
Income Before Tax(76M)(70M)(203M)(187M)
Pre-Tax Margin-3.4%-2.8%-7.5%-6.0%
Income Tax Expense16M38M48M128M
Net Income(96M)(112M)(250M)(331M)
Net Margin-4.3%-4.5%-9.2%-10.7%
EPS (Basic)(0.34)(0.40)(0.89)(1.29)
EPS (Diluted)(0.34)(0.40)(0.89)(1.29)
Weighted Avg Shares280.81M280.81M280.81M256.6M
Weighted Avg Shares (Diluted)280.81M280.81M280.81M256.6M

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.